Press releases

Professor Didier Samuel Appointed Chairman and Chief Executive Officer of Inserm

01 Feb 2023 | By Inserm (Newsroom) | Institutionnel et évènementiel

Didier Samuel PDG Inserm 1er février 2023

Didier-Samuel ® Christophe-PEUS

Appointed today in the Council of Ministers following the proposal of the Minister of Higher Education and Research and the Minister of Health and Prevention, Professor Didier Samuel becomes Chairman and Chief Executive Officer of Inserm.

Doctor and researcher, Didier Samuel has devoted himself to both fields throughout his career.

Professor of Hepatology at Université Paris-Saclay, Director of the Department of Hepatology and Hepatic Intensive Care at Paul-Brousse Hospital and Medical Director of the liver transplant program at the same hospital, Samuel has treated and monitored over 4,500 liver transplant patients. Dean of the Paris-Saclay Faculty of Medicine since 2017 and elected Chair of the Conference of Deans of Medicine in 2022, he also chaired France’s National Committee for Research Coordination.

Since 2005, Samuel led an Inserm research unit devoted to the physiopathogenesis and treatment of liver diseases. His expertise in the field of liver diseases and liver transplantation is internationally renowned.

“I am pleased and honored to have been appointed to carry out the important mission of chairing Inserm, which plays a central role in medical research in France. Committed to the quality of our scientific research, convinced that it is also the foundation for high-quality medicine, it is my wish to promote innovation, excellence, and fruitful coordination among all who endeavor for our biomedical research, serving the health of all citizens,” declares Professor Didier Samuel, Chairman and Chief Executive Officer of Inserm.

Press Contact